• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Marconi lists its stock on NASDAQ

Article

Global communications company Marconi is now listed on the NASDAQ stock exchange (MONI) in an effort to raise the firm's North American profile.International companies often find recruiting in the U.S. easier when domestic stock options can be provided

Global communications company Marconi is now listed on the NASDAQ stock exchange (MONI) in an effort to raise the firm's North American profile.

International companies often find recruiting in the U.S. easier when domestic stock options can be provided employees.

The U.K.-based firm, with some 49,000 employees worldwide, has previously been listed only on the London Exchange (also MONI). It describes itself as a company that specializes in "broadband infrastructure solutions

to telecommunications service providers and enterprises worldwide."

In the U.S., the firm's main presence is Marconi Medical Systems (formerly Picker International), headquartered in Cleveland, where it has 3500 employees.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.